Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe outer thigh is one of three licensed injection sites for Mounjaro (tirzepatide), alongside the abdomen and upper arm. It is suitable for most adults and is particularly easy to self-administer because you can see and reach the area without help. Mounjaro is a prescription-only medicine; a prescriber assesses whether it is clinically appropriate for you before any treatment begins. This guide covers correct thigh technique, how to rotate the site properly, and what to look out for after injecting.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Yes, and for many people it is the easiest one. The outer-thigh site is recommended in the Mounjaro Patient Information Leaflet because the area typically has enough subcutaneous fat to accommodate the short needle, and it sits right in your line of sight when you are seated. That matters more than it sounds: being able to see the pen properly before you press the plunger reduces the chance of rushing or mis-positioning.
A common belief is that the thigh produces more pain or bruising than the abdomen. In practice, discomfort varies between individuals and often depends more on technique than on the site itself. Injecting slowly, waiting for the skin to dry after cleaning, and keeping the KwikPen at room temperature for a few minutes before use all reduce the sharp sting that sometimes gets blamed on the location.
The one genuine limitation: if your thighs are quite lean, there may be less subcutaneous tissue to work with. In that case, a gentle skin-pinch before pressing the button can help ensure the medicine reaches the fatty layer rather than the muscle beneath, and our dedicated guide to the Mounjaro thigh injection site walks through exactly how to do this for different body types. If you are unsure, the prescribing team at our clinical team can advise on which site suits your build.
Target the front-outer surface of the mid-thigh, roughly the middle third of the distance between your knee and hip, on the outer side rather than the inner. Avoid the inner thigh (where friction from clothing and walking increases irritation), the area directly on the kneecap, and the very top of the thigh near the groin. You are also looking for clear, healthy skin: no active bruising, scarring, lumps, redness or areas of broken skin. The full Mounjaro injection site guidance covers all three sites in detail and is worth bookmarking.
Once you have chosen your spot, clean it with an alcohol swab and allow the skin to dry completely, injecting through wet skin stings noticeably more and the alcohol can slightly affect the tissue. Press the KwikPen flat against the skin at a 90-degree angle. Press the plunger button, hold for the count shown in your leaflet (typically around ten seconds), and then lift the pen straight away rather than at an angle. A slow, straight removal reduces bruising.
After injecting, you can press gently with a clean finger or a piece of gauze, but do not rub the site. Rubbing can spread the medicine unevenly and increase local irritation. You can find a full step-by-step on how the Mounjaro injection works in practice.
Rotation is not optional, it is clinically important. Using the same patch of skin each week can cause lipodystrophy, a change in the fatty tissue that creates hard lumps or hollows. Medicine absorbed through altered skin is less predictable, which matters more as your dose increases.
The simplest system is to divide each thigh into a grid of roughly palm-sized sections and move one section along each week. When you have covered the whole thigh, switch to a different site entirely, the abdomen or, if you prefer a hands-free option, the upper-arm site. Bringing all three sites into the rotation gives each area more time to recover fully between injections.
Some people find it helpful to write the site and date on a small sticky note inside their fridge, next to where they store the pen. A low-tech system, but it works. You do not need to use the same site at the same time of day; what matters is avoiding the same spot two weeks running. The tirzepatide thigh site overview has a useful diagram of the recommended grid pattern.
Mild reactions at the thigh are the most commonly reported local side effect across the Mounjaro clinical programme. Expect a small red mark, minor bruising, or a faint itch in the hours after injecting. These typically settle within 24 to 48 hours and do not require treatment beyond keeping the area clean. The NHS tirzepatide medicines page lists injection-site reactions as a common side effect and explains what the different categories of frequency mean.
Contact your prescriber if you notice a hard lump that does not disappear within a week or two (a sign of lipodystrophy, usually from insufficient rotation), spreading redness with warmth that could suggest infection, an unexplained rash beyond the injection point, or significant swelling. A severe allergic reaction is rare but serious: throat swelling, difficulty breathing and a widespread rash need emergency medical attention immediately.
If the pen itself did not inject correctly (for example the plunger did not complete its full travel) check the guidance on what to do if your Mounjaro pen is not turning before attempting a second injection. Never inject twice from the same pen without prescriber guidance, and always refer to your Patient Information Leaflet first. Patients can also report any suspected side effects directly to the MHRA via the Yellow Card scheme.
If you are not yet on Mounjaro and want to know whether it is right for you, the starting point is a free consultation with our prescribers, who review your answers the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.